{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T20:35:48Z","timestamp":1777840548254,"version":"3.51.4"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T00:00:00Z","timestamp":1596067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0235163","type":"journal-article","created":{"date-parts":[[2020,7,30]],"date-time":"2020-07-30T20:39:57Z","timestamp":1596141597000},"page":"e0235163","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association between proton pump inhibitor use and risk of fracture: A population-based case-control study"],"prefix":"10.1371","volume":"15","author":[{"given":"Jong Joo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-1895","authenticated-orcid":true,"given":"Hyun Soon","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,7,30]]},"reference":[{"key":"pone.0235163.ref001","first-page":"CD002095","article-title":"Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease","volume":"11","author":"B van Pinxteren","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0235163.ref002","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton\u2013pump inhibitors: understanding the complications and risks","volume":"14","author":"P Malfertheiner","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"pone.0235163.ref003","doi-asserted-by":"crossref","first-page":"171","DOI":"10.17480\/psk.2018.62.3.171","article-title":"Proton pump inhibitors\u2019 use in Korea based on the National Health Insurance Sample Cohort Database (2002\u20132013)","volume":"62","author":"JJ Kim","year":"2018","journal-title":"Yakhak Hoeji"},{"key":"pone.0235163.ref004","unstructured":"Health Insurance Review and Assessment Service [Internet]. Healthcare Bigdata Hub. Statistics [cited 2018, Jan 16]. Available from: http:\/\/opendata.hira.or.kr\/op\/opc\/olapMsupInfo.do."},{"key":"pone.0235163.ref005","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/CIRCULATIONAHA.108.191087","article-title":"ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents","volume":"118","author":"DL Bhatt","year":"2008","journal-title":"Circulation"},{"key":"pone.0235163.ref006","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s00774-012-0406-9","article-title":"The effects of risedronate administered in combination with a proton pump inhibitor for the treatment of osteoporosis","volume":"31","author":"S Itoh","year":"2013","journal-title":"J Bone Miner Metab"},{"key":"pone.0235163.ref007","doi-asserted-by":"crossref","first-page":"488","DOI":"10.18553\/jmcp.1998.4.5.488","article-title":"Alendronate use among 812 women: prevalence of gastrointestinal complaints, on compliance with patient instructions, and discontinuation","volume":"4","author":"B Ettinger","year":"1998","journal-title":"J Manag Care Pharm"},{"key":"pone.0235163.ref008","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4065\/77.3.262","article-title":"Upper gastrointestinal tract safety of risedronate: a pooled analysis of 9 clinical trials","volume":"77","author":"HT Aggart","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"pone.0235163.ref009","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00198-003-1399-y","article-title":"Pharmacovigilance study of alendronate in England","volume":"14","author":"PN Biswas","year":"2003","journal-title":"Osteoporos Int"},{"key":"pone.0235163.ref010","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00198-009-0891-4","article-title":"Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates","volume":"20","author":"F de Vries","year":"2009","journal-title":"Osteoporos Int"},{"key":"pone.0235163.ref011","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1365-2125.2004.02078.x","article-title":"Bisphosphonate use and subsequent prescription of acid suppressants","volume":"57","author":"EE Roughead","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"pone.0235163.ref012","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/jbmr.2011","article-title":"Predictors of fracture while on treatment with oral bisphosphonates: a population-based cohort study","volume":"29","author":"D Prieto-Alhambra","year":"2014","journal-title":"J Bone Miner Res"},{"key":"pone.0235163.ref013","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archinternmed.2011.20","article-title":"Proton pump inhibitor use and the antifracture efficacy of alendronate","volume":"171","author":"B Abrahamsen","year":"2011","journal-title":"Arch Intern Med"},{"key":"pone.0235163.ref014","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.bone.2010.12.015","article-title":"Meta-analysis: Risk of fractures with acid-suppressing medication","volume":"48","author":"CS Kwok","year":"2011","journal-title":"Bone"},{"key":"pone.0235163.ref015","first-page":"4899","article-title":"Bone fracture and the interaction between bisphosphonates and proton pump inhibitors: a meta-analysis","volume":"8","author":"SD Yang","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"pone.0235163.ref016","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00535-012-0722-9","article-title":"A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate","volume":"48","author":"J Lee","year":"2013","journal-title":"J Gastroenterol"},{"key":"pone.0235163.ref017","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1370\/afm.1243","article-title":"Use of acid-suppressive drugs and risk of fracture: a meta-analysis of observational studies","volume":"9","author":"CS Eom","year":"2011","journal-title":"Ann Fam Med"},{"key":"pone.0235163.ref018","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00198-015-3365-x","article-title":"Proton-pump inhibitors and risk of fractures: an update meta-analysis","volume":"27","author":"B Zhou","year":"2016","journal-title":"Osteoporos Int"},{"key":"pone.0235163.ref019","doi-asserted-by":"crossref","first-page":"141","DOI":"10.11005\/jbm.2018.25.3.141","article-title":"Proton-pump inhibitor use and fracture risk: an updated systematic review and meta-analysis","volume":"25","author":"Y Nassar","year":"2018","journal-title":"J Bone Metab"},{"key":"pone.0235163.ref020","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.296.24.2947","article-title":"Long-term proton pump inhibitor therapy and risk of hip fracture","volume":"296","author":"YX Yang","year":"2006","journal-title":"JAMA"},{"key":"pone.0235163.ref021","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02556841","article-title":"Omeprazole, a specific inhibitor of H+-K+-ATPase, inhibits bone resorption in vitro","volume":"38","author":"J Tuukkanen","year":"1986","journal-title":"Calcif Tissue Int"},{"key":"pone.0235163.ref022","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00001665-200305000-00007","article-title":"Proton pump inhibitors control osteoclastic resorption of calcium phosphate implants and stimulate increased local reparative bone growth","volume":"14","author":"K Rzeszutek","year":"2003","journal-title":"J Craniofac Surg"},{"key":"pone.0235163.ref023","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1053\/j.gastro.2009.11.014","article-title":"Proton pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss","volume":"138","author":"LE Targownik","year":"2010","journal-title":"Gastroenterology"},{"key":"pone.0235163.ref024","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/archinternmed.2010.94","article-title":"Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women","volume":"170","author":"SL Gray","year":"2010","journal-title":"Arch Intern Med"},{"key":"pone.0235163.ref025","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/jgs.13661","article-title":"Hyperparathyroidism associated with long-term proton pump inhibitors independent of concurrent bisphosphonate therapy in elderly adults","volume":"63","author":"AM Hinson","year":"2015","journal-title":"J Am Geriatr Soc"},{"key":"pone.0235163.ref026","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Postmenopausal osteoporosis","volume":"374","author":"DM Black","year":"2016","journal-title":"N Engl J Med"},{"key":"pone.0235163.ref027","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/psb.1815","article-title":"Diagnosis, assessment and management of osteoporosis","volume":"31","author":"R Blackie","year":"2020","journal-title":"Prescriber"},{"key":"pone.0235163.ref028","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MCG.0b013e31815ea27b","article-title":"Gastroesophageal reflux disease (GERD): risk factors, and impact on quality of life\u2014a population-based study","volume":"43","author":"GD Eslick","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"pone.0235163.ref029","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/EDE.0b013e3182093a0f","article-title":"Time-window bias in case-control studies: statins and lung cancer","volume":"22","author":"S Suissa","year":"2011","journal-title":"Epidemiology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235163","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T10:34:17Z","timestamp":1616841257000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0235163"}},"subtitle":[],"editor":[{"given":"Robert Daniel","family":"Blank","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,30]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0235163","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,30]]}}}